These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 24459786)

  • 41. Compounding pharmacy: old methods finding a new niche.
    Matheny C; Martin CM
    Consult Pharm; 2010 Jun; 25(6):357-63. PubMed ID: 20534406
    [TBL] [Abstract][Full Text] [Related]  

  • 42. USP general chapter <797> pharmaceutical compounding-sterile preparations.
    Hung JC
    J Nucl Med; 2004 Jun; 45(6):20N, 28N. PubMed ID: 15181114
    [No Abstract]   [Full Text] [Related]  

  • 43. Implementing United States Pharmacopeia Chapter <1163>. Quality assurance in pharmaceutical compounding, Part 3: Testing.
    Allen LV
    Int J Pharm Compd; 2012; 16(4):322-8. PubMed ID: 23050393
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Quality Control: Photodocumentation in Pharmacy Compounding.
    Allen LV
    Int J Pharm Compd; 2022; 26(2):116-117. PubMed ID: 35413010
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Brazilian National System for the Monitoring and Improvement of Compounding Practices: program outcomes.
    de Souza HG; Favaro A; Andrade AL; Gomes LY; Garcez Mdo C
    Int J Pharm Compd; 2012; 16(2):98-102. PubMed ID: 23050320
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A changing order for pharmacy.
    Vogenberg FR; Pisano DJ
    Hosp Pharm; 1995 Nov; 30(11):1002, 1005-6, 1008. PubMed ID: 10152915
    [No Abstract]   [Full Text] [Related]  

  • 47. [Tasks of the pharmacy network and service in improving the control of drug quality in light of the decisions of the 25th Congress of the CPSU].
    Uzdennikov OM
    Farm Zh; 1977; 32(4):10-3. PubMed ID: 913537
    [No Abstract]   [Full Text] [Related]  

  • 48. Compounding in Ukraine.
    Zdoryk OA; Georgiyants VA; Gryzodub OI; Schnatz R
    Int J Pharm Compd; 2013; 17(2):124-7. PubMed ID: 23696172
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Standards vs opinions.
    Allen LV
    Int J Pharm Compd; 2014; 18(2):92. PubMed ID: 24881110
    [No Abstract]   [Full Text] [Related]  

  • 50. [Ways to improve the control of drug quality].
    Babilev PV; Belikov VG
    Farm Zh; 1977; 32(4):3-9. PubMed ID: 913543
    [No Abstract]   [Full Text] [Related]  

  • 51. Patient safety issues associated with the use of compounded medicines as alternatives to approved pharmaceutical products in Europe and how best practice can improve outcomes.
    Isles M
    Int J Risk Saf Med; 2020; 31(3):133-144. PubMed ID: 32538874
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Description of outbreaks of health-care-associated infections related to compounding pharmacies, 2000-12.
    Staes C; Jacobs J; Mayer J; Allen J
    Am J Health Syst Pharm; 2013 Aug; 70(15):1301-12. PubMed ID: 23867487
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical Perspectives in Compounding: Compounding Gains and Losses Since I Met "Careless arithmetic nullifies careful compounding".
    Newton DW
    Int J Pharm Compd; 2015; 19(6):444-6. PubMed ID: 26891557
    [No Abstract]   [Full Text] [Related]  

  • 54. Implementing United States Pharmacopeia Chapter <1163> quality assurance in pharmaceutical compounding, Part 5: Outsourcing and responsible personnel.
    Allen LV
    Int J Pharm Compd; 2012; 16(6):490-6. PubMed ID: 23259367
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Investigation of product quality between extemporaneously compounded progesterone vaginal suppositories and an approved progesterone vaginal gel.
    Mahaguna V; McDermott JM; Zhang F; Ochoa F
    Drug Dev Ind Pharm; 2004; 30(10):1069-78. PubMed ID: 15595573
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Essential elements of quality control.
    Boylan JC
    Am J Hosp Pharm; 1983 Nov; 40(11):1936-9. PubMed ID: 6650523
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Performance measures in ambulatory pharmacy.
    MacKinnon N
    Pharm Pract Manag Q; 1997 Apr; 17(1):52-62. PubMed ID: 10166244
    [No Abstract]   [Full Text] [Related]  

  • 58. The "Lists": What Do They Mean?
    Voliva J
    Int J Pharm Compd; 2016; 20(6):477-479. PubMed ID: 28339386
    [No Abstract]   [Full Text] [Related]  

  • 59. The potential impact of usp general chapter <797> on procedures and requirements for the preparation of sterile radiopharmaceuticals.
    Hung JC
    J Nucl Med; 2004 Jun; 45(6):21N-6N. PubMed ID: 15181115
    [No Abstract]   [Full Text] [Related]  

  • 60. Report on the PQRI impurity characterization and quantification best practices survey.
    Faustino P; Chan CC; Carrano J; Gosnell M; Gu ZQ; Maule A; Sigvardson K; Zhang YF
    Pharm Res; 2006 Feb; 23(2):440-6. PubMed ID: 16477396
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.